Skip to content

Oncologix Tech Inc.: 10-Q filed 2012-07-16

What Oncologix Tech Inc. reported in its quarterly report filed 2012-07-16 (fiscal Q3 2012): 22 published measures, 62 facts as tagged in accession 0001471242-12-000951.

This filing

Form
10-Q (quarterly report)
Filed
2012-07-16
Fiscal period
fiscal Q3 2012
Accession
0001471242-12-000951 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Oncologix Tech Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-05-3114,211USD
At 2011-08-3115,371USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-05-31608,364USD
At 2011-08-31662,418USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-05-31-594,153USD
At 2011-08-31-647,047USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-05-317,139USD
At 2011-08-3111,067USD
At 2011-05-313,799USD
At 2010-08-3110,596USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-09-01 to 2012-05-31-224,039USD274
2011-06-01 to 2012-05-31-272,469USD366
2010-09-01 to 2011-05-31-187,179USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-09-01 to 2012-05-31-91,015USD274
2011-06-01 to 2012-05-31-158,044USD366
2010-09-01 to 2011-05-31-115,154USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2011-09-01 to 2012-05-311,677USD274
2011-06-01 to 2012-05-311,289USD366
2010-09-01 to 2011-05-31387USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-09-01 to 2012-05-31-1,677USD274
2011-06-01 to 2012-05-31-1,289USD366
2010-09-01 to 2011-05-31-387USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-05-31-58,004,869USD
At 2011-08-31-58,004,869USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-05-311,576USD
At 2011-08-31364USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2010-09-01 to 2011-05-31464USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-03-01 to 2012-05-31-29,628USD92
2011-09-01 to 2012-05-31-99,098USD274
2011-06-01 to 2012-05-31-133,640USD366
2011-03-01 to 2011-05-31-68,814USD92
2010-09-01 to 2011-05-31-161,996USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-05-3112,635USD
At 2011-08-3115,007USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-05-31248,339USD
At 2011-08-31662,418USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-03-01 to 2012-05-3129,628USD92
2011-09-01 to 2012-05-3199,098USD274
2011-06-01 to 2012-05-31133,640USD366
2011-03-01 to 2011-05-3168,814USD92
2010-09-01 to 2011-05-31161,996USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-05-3155,287,076shares
At 2011-08-3150,998,814shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-05-3157,631,227USD
At 2011-08-3157,358,582USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-05-318,821USD
At 2011-08-3121,682USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2012-05-315,496USD
At 2011-08-313,940USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2012-03-01 to 2012-05-31-35,975USD92
2011-09-01 to 2012-05-31-224,028USD274
2011-06-01 to 2012-05-31-272,455USD366
2011-03-01 to 2011-05-31-76,606USD92
2010-09-01 to 2011-05-31-187,169USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-03-01 to 2012-05-3129,533USD92
2011-09-01 to 2012-05-3198,743USD274
2011-06-01 to 2012-05-31132,769USD366
2011-03-01 to 2011-05-3168,496USD92
2010-09-01 to 2011-05-31161,042USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2011-09-01 to 2012-05-3175,000USD274
2011-06-01 to 2012-05-31175,000USD366
2010-09-01 to 2011-05-3175,000USD273

Inspect the source

Entity
Oncologix Tech Inc. / CIK 0000799694
Captured
SEC response SHA-256
acc83506e9d3f32d85d91503a2bd087a712fbc014fe7429b835fa6f76c6de48d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000799694.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))